PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States.\', \'Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, United States.\', \'Allergy Division, Department of Medicine, University of Virginia School of Medicine, Charlottesville, United States.\', \'Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, United States.\', \'Benaroya Research Institute at Virginia Mason, Seattle, United States.\', \'Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, United States.\', \'Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.64653e64653
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 34350827
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all